October 05, 2020 Few clues to flotation fever in past performance Investors are piling into biotech IPOs, but the track record of previous years' new issues shows how hard it is to pick winners.
April 09, 2020 Covid-19 stalls biotech flotations Several young drug developers managed to float in the first quarter, but new issues dried up in March when coronavirus infected the markets. Is the game back on?
